Clinical Trial Update: Safety and Effectiveness of IHAT in Iron Deficient Pre-menopausal Woman [Phase 3]

View source ↗

Summary

Phase 3 trial of IHAT for iron deficiency in pre-menopausal women has completed, evaluating safety and effectiveness.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Deficiency

Drugs mentioned

• IHAT

Snippet

Sponsor: RDC Clinical Pty Ltd | Conditions: Iron-deficiency | Phase 3 | Status: COMPLETED